Effect of Dose Adjustments on the Safety and Efficacy of Afatinib in Chinese Patients with EGFR-Mutated Non-Small Cell Lung Cancer Who Participated in the LUX-Lung Clinical Trial Program

OncoTargets and Therapy ◽

10.2147/ott.s273866 ◽

2020 ◽

Vol Volume 13 ◽

pp. 12539-12547

Author(s):

Hai-Yan Tu ◽

Yi-Long Wu

Keyword(s):

Lung Cancer ◽

Clinical Trial ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Chinese Patients ◽

Small Cell Lung ◽

Safety And Efficacy ◽

Clinical Trial Program

Download Full-text

Overview of the LUX-Lung clinical trial program of afatinib for non-small cell lung cancer

Cancer Treatment Reviews ◽

10.1016/j.ctrv.2018.06.018 ◽

2018 ◽

Vol 69 ◽

pp. 143-151 ◽

Cited By ~ 5

Author(s):

Namita Sharma ◽

Stephen Graziano

Keyword(s):

Lung Cancer ◽

Clinical Trial ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Clinical Trial Program

Download Full-text

Evaluation of safety and efficacy of gefitinib ('iressa', zd1839) as monotherapy in a series of Chinese patients with advanced non-small-cell lung cancer: experience from a compassionate-use programme

BMC Cancer ◽

10.1186/1471-2407-4-51 ◽

2004 ◽

Vol 4 (1) ◽

Cited By ~ 21

Author(s):

Xin-Lin Mu ◽

Long-Yun Li ◽

Xiao-Tong Zhang ◽

Shu-Lan Wang ◽

Meng-Zhao Wang

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Chinese Patients ◽

Compassionate Use ◽

Small Cell Lung ◽

Safety And Efficacy ◽

Cancer Experience

Download Full-text

Evaluation of safety and efficacy of ZD1839 as monotherapy for Chinese patients with advanced non-small cell lung cancer

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.7093 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7093-7093

Author(s):

X.-T. Zhang ◽

L. Li

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Chinese Patients ◽

Small Cell Lung ◽

Safety And Efficacy

Download Full-text

P3-139: Evaluation of safety and efficacy of Erlotinib (Tarceva) as monotherapy in a series of Chinese patients with advanced non–small–cell lung cancer: preliminary experience from an expanded access programme

Journal of Thoracic Oncology ◽

10.1097/01.jto.0000284114.49329.4b ◽

2007 ◽

Vol 2 (8) ◽

pp. S738-S739

Author(s):

Yuankai Shi ◽

Xiaohui He ◽

Lin Gui ◽

Sheng Yang

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Chinese Patients ◽

Small Cell Lung ◽

Safety And Efficacy ◽

Expanded Access ◽

Expanded Access Programme ◽

Access Programme

Download Full-text

Safety and efficacy of cetuximab combined with chemotherapy in Chinese patients with advanced non-small cell lung cancer

Thoracic Cancer ◽

10.1111/j.1759-7714.2011.00096.x ◽

2012 ◽

Vol 3 (2) ◽

pp. 188-193

Author(s):

Xiaoyan Si ◽

Li Zhang

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Chinese Patients ◽

Small Cell Lung ◽

Safety And Efficacy

Download Full-text

The LUX-Lung clinical trial program of afatinib for non-small-cell lung cancer

Expert Review of Anticancer Therapy ◽

10.1586/era.11.34 ◽

2011 ◽

Vol 11 (5) ◽

pp. 673-682 ◽

Cited By ~ 28

Author(s):

Giulio Metro ◽

Lucio Crinò

Keyword(s):

Lung Cancer ◽

Clinical Trial ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Clinical Trial Program

Download Full-text

Randomized clinical trial of pembrolizumab vs chemotherapy for previously untreated Chinese patients with PD‐L1 ‐positive locally advanced or metastatic non–small‐cell lung cancer: KEYNOTE ‐042 China Study

International Journal of Cancer ◽

10.1002/ijc.33399 ◽

2020 ◽

Author(s):

Yi‐Long Wu ◽

Li Zhang ◽

Yun Fan ◽

JianYing Zhou ◽

Li Zhang ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trial ◽

Small Cell Lung Cancer ◽

Randomized Clinical Trial ◽

Cell Lung Cancer ◽

Locally Advanced ◽

Small Cell ◽

Chinese Patients ◽

Small Cell Lung ◽

China Study

Download Full-text

Evaluation of safety and efficacy of ZD1839 as monotherapy for Chinese patients with advanced non-small cell lung cancer

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.7093 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7093-7093

Author(s):

X.-T. Zhang ◽

L. Li

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Chinese Patients ◽

Small Cell Lung ◽

Safety And Efficacy

Download Full-text

A Study to Investigate the Safety and Efficacy of Atezolizumab in Previously-Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Case Medical Research ◽

10.31525/ct1-nct03922997 ◽

2019 ◽

Author(s):

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung ◽

Safety And Efficacy ◽

Previously Treated Patients ◽

Previously Treated

Download Full-text

Faculty Opinions recommendation of Safety and efficacy of weekly nab®-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717964584.793468557 ◽

2013 ◽

Author(s):

Bruno Andreoni ◽

Gianmarco Contino

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Safety And Efficacy ◽

First Line Therapy ◽

Line Therapy

Download Full-text